← Evidence map

ArticleJournal of hematology & oncology2026

Advances in first-line treatment for primary central nervous system lymphoma: highlights from the 2025 ASH annual meeting.

Rong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41957790